Clinical and genetic features of cervical dystonia in a large multicenter cohort
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To characterize the clinical and genetic features of cervical dystonia (CD).
Methods: Participants enrolled in the Dystonia Coalition biorepository (NCT01373424) with initial manifestation as CD were included in this study (n = 1,000). Data intake included demographics, family history, and the Global Dystonia Rating Scale. Participants were screened for sequence variants (SVs) in GNAL, THAP1, and Exon 5 of TOR1A.
Results: The majority of participants were Caucasian (95%) and female (75%). The mean age at onset and disease duration were 45.5 ± 13.6 and 14.6 ± 11.8 years, respectively. At the time of assessment, 68.5% had involvement limited to the neck, shoulder(s), and proximal arm(s), whereas 47.4% had dystonia limited to the neck. The remaining 31.5% of the individuals exhibited more extensive anatomical spread. A head tremor was noted in 62% of the patients. Head tremor and laryngeal dystonia were more common in females. Psychiatric comorbidities, mainly depression and anxiety, were reported by 32% of the participants and were more common in females. Family histories of dystonia, parkinsonian disorder, and tremor were present in 14%, 11%, and 29% of the patients, respectively. Pathogenic or likely pathogenic SVs in THAP1, TOR1A, and GNAL were identified in 8 participants (0.8%). Two individuals harbored novel missense SVs in Exon 5 of TOR1A. Synonymous and noncoding SVs in THAP1 and GNAL were identified in 4% of the cohort.
Conclusions: Head tremor, laryngeal dystonia, and psychiatric comorbidities are more common in female participants with CD. Coding and noncoding variants in GNAL, THAP1, and TOR1A make small contributions to the pathogenesis of CD.
GLOSSARY
- 1KG=
- 1000 Genomes Project;
- CADD=
- Combined Annotation-Dependent Depletion;
- CD=
- cervical dystonia;
- DC=
- Dystonia Coalition;
- ESE=
- exonic splicing enhancer;
- ESS=
- exonic splicing silencer;
- EVS=
- Exome Variant Server;
- ExAC=
- Exome Aggregation Consortium;
- GDRS=
- Global Dystonia Rating Scale;
- HRM=
- high-resolution melting;
- miRNA=
- microRNA;
- PolyPhen-2=
- Polymorphism Phenotyping version 2;
- SV=
- sequence variant;
- SWEDDs=
- scans without evidence of dopaminergic deficit;
- UTHSC=
- University of Tennessee Health Science Center
Footnotes
Coinvestigators are listed at Neurology.org/ng.
Funding information and disclosures are provided at the end of the article. Go to Neurology.org/ng for full disclosure forms. The Article Processing Charge was paid by the authors.
Supplemental data at Neurology.org/ng
- Received February 5, 2016.
- Accepted in final form March 1, 2016.
- © 2016 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Novel THAP1 sequence variants in primary dystoniaJ. Xiao, Y. Zhao, R. W. Bastian et al.Neurology, January 18, 2010 -
Article
Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystoniaNorbert Brüggemann, Andrea Kühn, Susanne A. Schneider et al.Neurology, February 04, 2015 -
Five New Things
DystoniaFive new thingsBrian D. Berman, H.A. Jinnah et al.Neurology: Clinical Practice, February 12, 2015 -
Articles
Age at onset as a factor in determining the phenotype of primary torsion dystoniaS. O’Riordan, D. Raymond, T. Lynch et al.Neurology, October 25, 2004